Development of liver regenerative therapy using glycoside-modified bone marrow cells

Ryosuke Misawa, Hirohiko Ise, Masafumi Takahashi, Hajime Morimoto, Eiji Kobayashi, Shin Ichi Miyagawa, Uichi Ikeda

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Several recent studies have reported that bone marrow cells (BMCs) have the ability to generate functional hepatocytes. However, the efficiency at which BMC transplantation generates functional hepatocytes is rather low. We assumed that if BMCs accumulated directly in liver, the functional BMC-derived hepatocytes should increase efficiently. We tried to increase the accumulation of BMCs directly in liver through the interaction between hepatic asialoglycoprotein receptor and desialylated BMCs. Desialylated BMCs were produced with treatment of neuraminidase. Desialylated BMCs that expressed green fluorescent protein (GFP) were injected into Long Evans Cinnamon (LEC) rats, a human Wilson's disease model, intravenously. At 3 and 5 months after transplantation, GFP-expressing hepatocyte nodules appeared in the liver of these BMC-transplanted LEC rats. These findings suggest that the functional BMC-derived hepatocytes can be generated by the direct accumulation of BMCs and that this strategy is new BMC therapy for liver regeneration.

Original languageEnglish
Pages (from-to)434-440
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume342
Issue number2
DOIs
Publication statusPublished - Apr 7 2006
Externally publishedYes

Fingerprint

Glycosides
Bone Marrow Cells
Liver
Bone
Cells
Hepatocytes
Inbred LEC Rats
Therapeutics
Green Fluorescent Proteins
Rats
Asialoglycoprotein Receptor
Hepatolenticular Degeneration
Liver Regeneration
Neuraminidase
Cell- and Tissue-Based Therapy
Bone Marrow Transplantation
Transplantation

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Development of liver regenerative therapy using glycoside-modified bone marrow cells. / Misawa, Ryosuke; Ise, Hirohiko; Takahashi, Masafumi; Morimoto, Hajime; Kobayashi, Eiji; Miyagawa, Shin Ichi; Ikeda, Uichi.

In: Biochemical and Biophysical Research Communications, Vol. 342, No. 2, 07.04.2006, p. 434-440.

Research output: Contribution to journalArticle

Misawa, Ryosuke ; Ise, Hirohiko ; Takahashi, Masafumi ; Morimoto, Hajime ; Kobayashi, Eiji ; Miyagawa, Shin Ichi ; Ikeda, Uichi. / Development of liver regenerative therapy using glycoside-modified bone marrow cells. In: Biochemical and Biophysical Research Communications. 2006 ; Vol. 342, No. 2. pp. 434-440.
@article{aa7d8d7452c748b5afda029d5484a4a4,
title = "Development of liver regenerative therapy using glycoside-modified bone marrow cells",
abstract = "Several recent studies have reported that bone marrow cells (BMCs) have the ability to generate functional hepatocytes. However, the efficiency at which BMC transplantation generates functional hepatocytes is rather low. We assumed that if BMCs accumulated directly in liver, the functional BMC-derived hepatocytes should increase efficiently. We tried to increase the accumulation of BMCs directly in liver through the interaction between hepatic asialoglycoprotein receptor and desialylated BMCs. Desialylated BMCs were produced with treatment of neuraminidase. Desialylated BMCs that expressed green fluorescent protein (GFP) were injected into Long Evans Cinnamon (LEC) rats, a human Wilson's disease model, intravenously. At 3 and 5 months after transplantation, GFP-expressing hepatocyte nodules appeared in the liver of these BMC-transplanted LEC rats. These findings suggest that the functional BMC-derived hepatocytes can be generated by the direct accumulation of BMCs and that this strategy is new BMC therapy for liver regeneration.",
author = "Ryosuke Misawa and Hirohiko Ise and Masafumi Takahashi and Hajime Morimoto and Eiji Kobayashi and Miyagawa, {Shin Ichi} and Uichi Ikeda",
year = "2006",
month = "4",
day = "7",
doi = "10.1016/j.bbrc.2006.01.169",
language = "English",
volume = "342",
pages = "434--440",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Development of liver regenerative therapy using glycoside-modified bone marrow cells

AU - Misawa, Ryosuke

AU - Ise, Hirohiko

AU - Takahashi, Masafumi

AU - Morimoto, Hajime

AU - Kobayashi, Eiji

AU - Miyagawa, Shin Ichi

AU - Ikeda, Uichi

PY - 2006/4/7

Y1 - 2006/4/7

N2 - Several recent studies have reported that bone marrow cells (BMCs) have the ability to generate functional hepatocytes. However, the efficiency at which BMC transplantation generates functional hepatocytes is rather low. We assumed that if BMCs accumulated directly in liver, the functional BMC-derived hepatocytes should increase efficiently. We tried to increase the accumulation of BMCs directly in liver through the interaction between hepatic asialoglycoprotein receptor and desialylated BMCs. Desialylated BMCs were produced with treatment of neuraminidase. Desialylated BMCs that expressed green fluorescent protein (GFP) were injected into Long Evans Cinnamon (LEC) rats, a human Wilson's disease model, intravenously. At 3 and 5 months after transplantation, GFP-expressing hepatocyte nodules appeared in the liver of these BMC-transplanted LEC rats. These findings suggest that the functional BMC-derived hepatocytes can be generated by the direct accumulation of BMCs and that this strategy is new BMC therapy for liver regeneration.

AB - Several recent studies have reported that bone marrow cells (BMCs) have the ability to generate functional hepatocytes. However, the efficiency at which BMC transplantation generates functional hepatocytes is rather low. We assumed that if BMCs accumulated directly in liver, the functional BMC-derived hepatocytes should increase efficiently. We tried to increase the accumulation of BMCs directly in liver through the interaction between hepatic asialoglycoprotein receptor and desialylated BMCs. Desialylated BMCs were produced with treatment of neuraminidase. Desialylated BMCs that expressed green fluorescent protein (GFP) were injected into Long Evans Cinnamon (LEC) rats, a human Wilson's disease model, intravenously. At 3 and 5 months after transplantation, GFP-expressing hepatocyte nodules appeared in the liver of these BMC-transplanted LEC rats. These findings suggest that the functional BMC-derived hepatocytes can be generated by the direct accumulation of BMCs and that this strategy is new BMC therapy for liver regeneration.

UR - http://www.scopus.com/inward/record.url?scp=33344471958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33344471958&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2006.01.169

DO - 10.1016/j.bbrc.2006.01.169

M3 - Article

C2 - 16487486

AN - SCOPUS:33344471958

VL - 342

SP - 434

EP - 440

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -